RealD added to Focus List at B. Riley Caris B. Riley Caris added RealD to its Focus List given an improved near-term outlook and expectations for a significant ramp in 2013 3D movie releases. Shares are Buy rated with a $16 price target.
News For RLD From The Last 14 Days
Check below for free stories on RLD the last two weeks.
BioScrip, InterXion, RealD mentioned as stock picks by Oscar Schafer Pharmacy and home health services provider BioScrip (BIOS) was named as a stock pick and a potential takeover target by Oscar Schafer, managing partner of O.S.S. Capital Management and chairman of Rivulet Capital, while speaking on CNBC. Schafer also mentioned data center service provider InterXion (INXN) and 3D technology licensor RealD (RLD) as stock picks during his appearance on the network.